Mona Arafa | Health Professions | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Mona Arafa | Health Professions | Best Researcher Award

Faculty of Pharmacy at University of Tabuk, Saudi Arabia.

Dr. Mona Farouk Mahmoud Arafa is an accomplished Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She earned her Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, focusing on enhancing oral bioavailability through drug crystalline structure modification. With a solid foundation in pharmacy, she has progressed through various academic roles, from Demonstrator to Associate Professor, and actively contributes to departmental committees and quality assurance initiatives. Dr. Arafa’s research interests center on the formulation and evaluation of microemulsions, niosomes, and colloidal systems to improve transdermal drug delivery and oral absorption. She has authored numerous publications in reputable journals and has extensive experience with advanced techniques such as high-performance liquid chromatography and differential scanning calorimetry. Dr. Arafa is committed to advancing pharmaceutical sciences and education, having participated in various training programs to enhance her teaching and research capabilities.

Profile:

Education

Dr. Mona Farouk Mahmoud Arafa holds an impressive educational background in the field of pharmacy and pharmaceutical technology. She earned her Bachelor’s degree in Pharmacy from the University of Tanta, Egypt, in 2009, graduating with a general grade of “Excellent with Honor.” She then pursued her Master’s degree in Pharmaceutical Technology at the same institution, completing her thesis on the optimization of colloidal carriers for the simultaneous transdermal delivery of two drugs in 2013. Dr. Arafa continued her academic journey by obtaining her Ph.D. in Pharmaceutical Technology in 2017, also from the University of Tanta. Her doctoral research focused on the investigation of drug crystalline structure modification as a tool for enhancing oral bioavailability. This strong educational foundation has equipped Dr. Arafa with the knowledge and expertise necessary to excel in her role as an associate professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia.

Professional Experience

Dr. Mona Farouk Mahmoud Arafa is an accomplished academic and researcher in the field of Pharmaceutical Technology, currently serving as an Associate Professor in the Pharmaceutics Department at Tabuk University, Saudi Arabia. She holds a Ph.D. in Pharmaceutical Technology from the University of Tanta, Egypt, where her research focused on enhancing oral bioavailability through drug crystalline structure modification. Dr. Arafa has progressively advanced through various academic ranks, starting as a Demonstrator and rising to her current position. Her administrative roles include membership in departmental councils, student affairs committees, and quality assurance units. With a strong emphasis on research, Dr. Arafa has authored numerous publications in esteemed journals, contributing to advancements in drug delivery systems, microemulsions, and transdermal formulations. Her expertise is complemented by active participation in training programs and workshops, enhancing her skills in crisis management, international publishing, and digital transformation within higher education.

Research Interest

Dr. Mona Farouk Mahmoud Arafa’s research interests lie in the field of pharmaceutical technology, with a particular focus on enhancing drug delivery systems. Her work involves the formulation, characterization, and evaluation of innovative colloidal carriers, including microemulsions and niosomes, aimed at improving transdermal drug delivery. Dr. Arafa employs advanced analytical techniques such as differential scanning calorimetry, X-ray powder diffraction, and Fourier transform infrared spectroscopy to study the modulation of crystalline structures in drugs. This research is pivotal in understanding how drug interactions with various co-processors can enhance oral bioavailability and absorption. Additionally, she investigates the applications of novel excipients and co-crystal formations to optimize drug dissolution rates. Through her comprehensive approach, Dr. Arafa contributes significantly to the development of advanced pharmaceutical formulations, striving to address challenges in drug delivery and improve therapeutic outcomes for patients.

Research Skills

Dr. Mona Farouk Mahmoud Arafa possesses a robust set of research skills that significantly contribute to her expertise in pharmaceutical technology. Her proficiency in formulating, characterizing, and evaluating various drug delivery systems, including microemulsions and niosomes, showcases her ability to innovate in the field. Dr. Arafa is adept in employing advanced analytical techniques, such as high-performance liquid chromatography, differential scanning calorimetry, and X-ray powder diffraction, to assess drug crystalline structures and enhance oral bioavailability. Her extensive publication record in peer-reviewed journals highlights her capability to conduct rigorous research, analyze complex data, and communicate findings effectively. Additionally, her experience in collaborative research and training programs underscores her commitment to academic excellence and professional development. Dr. Arafa’s skill set not only emphasizes her technical expertise but also reflects her dedication to advancing pharmaceutical sciences and improving patient outcomes through innovative drug delivery systems.

Award and Recognition

Dr. Mona Farouk Mahmoud Arafa, an esteemed Associate Professor in the Pharmaceutics Department at Tabuk University, has received numerous awards and recognitions for her exceptional contributions to pharmaceutical technology. Her groundbreaking research, particularly in the enhancement of oral bioavailability and transdermal drug delivery systems, has been published in high-impact journals, earning her a respected reputation in the academic community. Dr. Arafa’s innovative work on drug crystalline structure modification and the development of novel colloidal carriers has not only advanced scientific understanding but also significantly impacted pharmaceutical practices. She has been actively involved in training programs and workshops, fostering a culture of excellence in education and research. Additionally, her leadership roles within various academic committees reflect her commitment to quality assurance in higher education. Dr. Arafa’s dedication to her field, combined with her extensive research output, underscores her eligibility for recognition as a leading researcher in the pharmaceutical sciences.

Conclusion

Dr. Mona Farouk Mahmoud Arafa is a highly qualified candidate for the Best Researcher Award, exemplifying dedication to research, education, and academic leadership. Her extensive publications, innovative research in drug delivery systems, and administrative roles underscore her commitment to advancing pharmaceutical sciences. By addressing areas for improvement, particularly in networking and public engagement, Dr. Arafa can further elevate her contributions to the field and enhance her influence as a researcher and educator. Recognizing her with this award would not only honor her achievements but also inspire others in the academic community.

Publication Top Notes

  • Aerosil as a novel co-crystal co-former for improving the dissolution rate of hydrochlorothiazide
    • Authors: SA El-Gizawy, MA Osman, MF Arafa, GM El Maghraby
    • Year: 2015
  • Sucralose as co-crystal co-former for hydrochlorothiazide: development of oral disintegrating tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2016
  • Chitosan coated nanostructured lipid carriers for enhanced in vivo efficacy of albendazole against Trichinella spiralis
    • Authors: RK Eid, DS Ashour, EA Essa, GM El Maghraby, MF Arafa
    • Year: 2020
  • Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2018
  • Co-crystallization for enhanced dissolution rate of nateglinide: In vitro and in vivo evaluation
    • Authors: MF Arafa, SA El-Gizawy, MA Osman, GM El Maghraby
    • Year: 2017
  • Microemulsion for simultaneous transdermal delivery of benzocaine and indomethacin: in vitro and in vivo evaluation
    • Authors: GM El Maghraby, MF Arafa, MA Osman
    • Year: 2014
  • Lidocaine as eutectic forming drug for enhanced transdermal delivery of nonsteroidal anti-inflammatory drugs
    • Authors: HF Marei, MF Arafa, EA Essa, GM El Maghraby
    • Year: 2021
  • Niosomal versus nano-crystalline ivermectin against different stages of Trichinella spiralis infection in mice
    • Authors: DA Elmehy, MA Hasby Saad, GM El Maghraby, MF Arafa, NA Soliman, …
    • Year: 2021

 

Hyun-Soo Choi | Medical Domain | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Hyun-Soo Choi | Medical Domain | Best Researcher Award

Assistant Professor at Seoul National University of Science and Technology, South Korea

Dr. Hyun-Soo Choi is an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology. He holds a Ph.D. in Electrical and Computer Engineering from Seoul National University. His research focuses on artificial intelligence, machine learning, deep learning, biomedical data learning, and causal inference. With significant contributions to the field, Dr. Choi has published extensively in renowned journals, including IEEE Transactions on Neural Networks and Learning Systems and the Journal of Clinical Medicine. His work on deep learning-based medical diagnostics and imbalanced data classification has garnered attention for its innovative approaches and practical applications. In addition to his academic role, he serves as the Chief Technical Officer at Ziovision and has previously worked as a researcher at SK Telecom. Dr. Choi has received accolades such as the Annual Excellence Award from Seoul National University, recognizing his impactful research and academic achievements.

Profile

Education

Dr. Hyun-Soo Choi’s educational journey is marked by distinguished achievements and a solid foundation in engineering and computer science. He earned his Bachelor of Science degree in Computer and Communication Engineering from Korea University in February 2013, where he developed a strong base in computing principles. He then pursued advanced studies at Seoul National University, completing his Ph.D. in Electrical and Computer Engineering in February 2020. During his doctoral studies, he was supervised by Prof. Sungroh Yoon and focused on “Imbalanced Data Learning: Advances in Techniques and Applications,” contributing significant advancements to the field of artificial intelligence and machine learning. This academic background not only reflects his expertise in data analysis and bio-medical data learning but also highlights his commitment to advancing knowledge through innovative research.

Professional Experience

Dr. Hyun-Soo Choi has accumulated a diverse range of professional experiences across academia and industry. Currently, he serves as an Assistant Professor in the Department of Computer Science and Engineering at Seoul National University of Science and Technology since February 2023. In this role, he teaches advanced courses in programming, natural language processing, and deep learning. Concurrently, Dr. Choi is the Chief Technical Officer at Ziovision, overseeing technological innovations and developments since October 2021. Previously, he was an Assistant Professor at Kangwon National University from March 2021 to February 2023, where he contributed to various courses on data analysis and machine learning. Dr. Choi also has experience as a researcher at SK Telecom’s T-brain, focusing on advanced artificial intelligence applications from February 2020 to February 2021. His academic background includes a Ph.D. from Seoul National University, where he was mentored by Prof. Sungroh Yoon.

 Research Interest

Dr. Hyun-Soo Choi’s research focuses on advanced artificial intelligence (AI) and machine learning techniques, with a particular emphasis on deep learning, universal learning machines, and causal inference. His work addresses the challenges of bio-medical data learning, aiming to enhance the accuracy and efficiency of data-driven healthcare solutions. Dr. Choi’s research contributions include developing innovative algorithms for imbalanced data learning and applying deep learning methods to various medical fields, such as organ localization and ECG analysis. His recent projects explore novel approaches in facial fracture detection, drug monitoring, and real-time health monitoring, underscoring his commitment to translating AI advancements into practical medical applications. By integrating interdisciplinary methodologies, Dr. Choi strives to push the boundaries of AI research, improving diagnostic and predictive capabilities in healthcare and beyond.

 Research Skills

Dr. Hyun-Soo Choi exhibits a broad and advanced skill set in artificial intelligence and machine learning, particularly in deep learning, causal inference, and bio-medical data analysis. His expertise spans a range of research techniques, including the development of advanced algorithms for imbalanced data learning and generative adversarial networks (GANs). Dr. Choi is proficient in employing deep learning models for diverse applications, such as facial fracture detection, organ localization in wireless capsule endoscopy, and electrocardiography analysis. His ability to integrate machine learning methods with real-world medical data demonstrates a strong aptitude for translating complex theoretical models into practical solutions. Additionally, Dr. Choi’s experience with causal inference methods and universal learning machines highlights his skill in handling intricate data structures and extracting meaningful insights. His comprehensive understanding of these areas is evident through his numerous high-impact publications and contributions to cutting-edge research in his field.

Conclusion

Dr. Hyun-Soo Choi is a strong candidate for the “Research for Best Researcher Award” due to his prolific research output, interdisciplinary expertise, and leadership roles in both academia and industry. However, to further strengthen his application, it would be beneficial to highlight his success in securing research funding, previous awards or recognitions, mentorship activities, and the broader societal impact of his research. With these additions, Dr. Choi would present a well-rounded profile that exemplifies excellence in research and its application to solving real-world challenges.

 

Publications Top Notes

  • A Comprehensive Study on a Deep-Learning-Based Electrocardiography Analysis for Estimating the Apnea-Hypopnea Index
    • Authors: Kim, S., Choi, H.-S., Kim, D., … Kim, Y., Lee, W.H.
    • Year: 2024
  • A Deep Learning–Based Approach for Prediction of Vancomycin Treatment Monitoring: Retrospective Study Among Patients With Critical Illness
    • Authors: Kim, D., Choi, H.-S., Lee, D., … Park, J.-H., Park, J.
    • Year: 2024
    • Citations: 1
  • Early Prediction of Mortality for Septic Patients Visiting Emergency Room Based on Explainable Machine Learning: A Real-World Multicenter Study
    • Authors: Park, S.W., Yeo, N.Y., Kang, S., … Lim, C.-M., Heo, J.
    • Year: 2024
    • Citations: 2
  • Explicit Feature Interaction-Aware Graph Neural Network
    • Authors: Kim, M., Choi, H.-S., Kim, J.
    • Year: 2024
    • Citations: 1
  • In-Advance Prediction of Pressure Ulcers via Deep-Learning-Based Robust Missing Value Imputation on Real-Time Intensive Care Variables
    • Authors: Kim, M., Kim, T.-H., Kim, D., … Han, S.-S., Choi, H.-S.
    • Year: 2024
  • Improving Generalization Performance of Electrocardiogram Classification Models
    • Authors: Han, H., Park, S., Min, S., … Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • On the Impact of Knowledge Distillation for Model Interpretability
    • Authors: Han, H., Siwon, K., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 1
  • Multi-View Computed Tomography Network for Osteoporosis Classification
    • Authors: Hwang, D.H., Bak, S.H., Ha, T.-J., … Kim, W.J., Choi, H.-S.
    • Year: 2023
    • Citations: 1
  • PixelSteganalysis: Pixel-Wise Hidden Information Removal With Low Visual Degradation
    • Authors: Jung, D., Bae, H., Choi, H.-S., Yoon, S.
    • Year: 2023
    • Citations: 3
  • ConBERT: A Concatenation of Bidirectional Transformers for Standardization of Operative Reports from Electronic Medical Records
    • Authors: Park, S., Bong, J.-W., Park, I., … Choi, H.-S., Kang, S.
    • Year: 2022
    • Citations: 1

 

Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Posted on by ScienceFather

Mrs. Imelda Rocío Guzmán Cervantes | Health Professions | Health Innovator’s Leadership Award

Directora Ejecutiva de Control Analítico at Comisión Federal para la Protección contra Riesgos Sanitarios, Mexico

Mrs. Imelda Rocío Guzmán Cervantes is a highly accomplished professional in pharmaceutical chemistry and public health regulation. With a Master’s degree in Innovation and Technology Management from UNAM, where she earned an Honorable Mention for her thesis on the impact of transnational corporations on the pharmaceutical industry, her academic foundation is robust. She also holds a Bachelor’s degree in Pharmaceutical Chemistry Biology from UNAM, complemented by diplomas in Total Quality Control and Leadership from UPIICSA and Anáhuac University. Currently serving as the Executive Director of Analytical Control at COFEPRIS, Mrs. Guzmán Cervantes plays a pivotal role in overseeing the National Control Laboratory, ensuring the safety of products such as vaccines and medical devices. Her leadership has been instrumental in COFEPRIS’s recognition by WHO and PAHO, and she has actively contributed to international regulatory projects and workshops. Her work, including publications on the role of regulatory agencies during the COVID-19 pandemic, underscores her dedication to enhancing public health safety and regulatory standards.

Profile
Education

Mrs. Imelda Rocío Guzmán Cervantes has a robust educational background that has significantly contributed to her expertise in the fields of pharmaceutical chemistry, quality control, and innovation management. She earned her Master’s degree in Innovation and Technology Management from the Faculty of Chemistry at UNAM, where she received an Honorable Mention for her thesis on the strategies of transnational corporations and their impact on the national pharmaceutical industry. Earlier, she completed her undergraduate studies in Pharmaceutical Chemistry Biology at UNAM, where she engaged in research on the development and implementation of a master plan for validating cleaning processes in pharmaceutical production. Mrs. Guzmán Cervantes has also pursued specialized diplomas in Total Quality Control from UPIICSA and in Leadership and Personal Development from Anáhuac University. Additionally, she completed a graduate program in Management Systems Monitoring Product Safety Market at Universitat Pompeu Fabra in Barcelona, further enhancing her expertise in ensuring product safety in the healthcare sector. Her educational journey reflects a strong commitment to continuous learning and excellence in her field.

Professional Experience

Mrs. Imelda Rocío Guzmán Cervantes has built a distinguished career in pharmaceutical regulation and quality assurance. Since 2009, she has been with COFEPRIS, the Federal Commission for Protection against Sanitary Risk in Mexico, where she currently serves as the Executive Director of Analytical Control. In this role, she leads the National Control Laboratory, overseeing the analysis of vaccines, food, drugs, and medical devices to ensure their safety and efficacy. Her tenure at COFEPRIS includes significant achievements such as facilitating the agency’s recognition as a National Regulatory Authority by WHO and PAHO, and securing WHO prequalification for its laboratory. Prior to her current position, Mrs. Guzmán Cervantes worked as a Technical Advisor to the Commissioner and played a key role in establishing policies and coordinating international relationships. She also gained valuable experience as a Validation Coordinator at Protein S.A. de C.V., where she focused on quality assurance in the pharmaceutical industry. Her extensive experience underscores her commitment to enhancing public health safety and regulatory standards.

Research Interests

Mrs. Imelda Rocío Guzmán Cervantes’s research interests primarily focus on pharmaceutical regulation, quality control, and public health safety. Her work is centered on the development and implementation of regulatory frameworks and methodologies to ensure the safety and efficacy of pharmaceuticals and medical devices. She is particularly interested in the impact of regulatory practices on public health, as demonstrated by her research on the role of national regulatory agencies during the COVID-19 pandemic. Additionally, Mrs. Guzmán Cervantes explores innovations in quality control processes and the integration of international standards into national regulatory practices. Her research aims to advance the effectiveness of regulatory systems and enhance the overall safety of pharmaceutical products and medical devices.

Research Skills

Mrs. Imelda Rocío Guzmán Cervantes possesses a robust set of research skills tailored to her expertise in pharmaceutical regulation and quality control. She excels in developing and implementing regulatory frameworks and quality control processes to ensure the safety and efficacy of pharmaceutical products, medical devices, and vaccines. Her analytical skills include applying various techniques for evaluating product quality and utilizing data analysis tools to interpret research findings effectively. Mrs. Guzmán Cervantes is adept at creating detailed documentation and reports related to regulatory compliance and quality assurance. She is well-versed in international regulatory standards and practices, particularly those established by WHO and PAHO, and integrates these standards into national regulatory systems. Her project management skills enable her to oversee complex research projects, coordinate activities, and ensure adherence to regulatory requirements. Additionally, her research on the impact of regulatory agencies during health crises, such as the COVID-19 pandemic, underscores her commitment to advancing public health safety.

Awards and Recognition

Mrs. Imelda Rocío Guzmán Cervantes has received notable awards and recognition for her distinguished work in pharmaceutical regulation and quality control. Her leadership was pivotal in the recognition of COFEPRIS as a National Regulatory Authority by the World Health Organization (WHO) and the Pan American Health Organization (PAHO). Under her guidance, the National Control Laboratory (CCAYAC) achieved WHO prequalification for drug analysis, reflecting her commitment to maintaining high standards in regulatory practices. Additionally, she has been honored for her contributions as a facilitator and auditor in international regulatory workshops and evaluations, including those for GAVI countries and the Directorate General of Medicines in Peru. These accolades underscore her impactful role in advancing global public health and regulatory standards.

Conclusion

Mrs. Imelda Rocío Guzmán Cervantes’s blend of leadership, regulatory expertise, innovation in public health, and continuous dedication to professional development makes her an ideal candidate for the Health Innovator’s Leadership Award. Her contributions have had a lasting impact on both national and international public health, making her highly deserving of this recognition.

Publications Top Notes

Title: Importance of national regulatory agencies and national control laboratories in the face of the COVID-19 pandemic: Experience of Federal Commission for the Protection against Sanitary Risks (COFEPRIS)
Title (Spanish): Importancia de las agencias reguladoras nacionales y los laboratorios nacionales de control ante la pandemia de COVID-19: experiencia de la Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS)
Authors: Guzmán-Cervantes, I.R., Parra-Hernández, E., Svarch-Pérez, A.E., Zúñiga-Estrada, A., Alcocer-Varela, J.C.
Journal: Vacunas
Year: 2024
Volume: 25
Issue: 3
Pages: 424–427